These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32622720)

  • 21. Long noncoding RNAs and prostate carcinogenesis: the missing 'linc'?
    Walsh AL; Tuzova AV; Bolton EM; Lynch TH; Perry AS
    Trends Mol Med; 2014 Aug; 20(8):428-36. PubMed ID: 24836411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of 10 differently expressed lncRNAs as prognostic biomarkers for prostate adenocarcinoma.
    Wu ZY; Wang SG; Li Q; Zhao QS; Shao MM
    Math Biosci Eng; 2019 Dec; 17(3):2037-2047. PubMed ID: 32233522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long noncoding RNA in prostate, bladder, and kidney cancer.
    Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
    Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The emerging role of noncoding RNA in prostate cancer progression and its implication on diagnosis and treatment.
    Takayama K; Inoue S
    Brief Funct Genomics; 2016 May; 15(3):257-65. PubMed ID: 26685282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer Metabolism.
    Shih JW; Wang LY; Hung CL; Kung HJ; Hsieh CL
    Int J Mol Sci; 2015 Dec; 16(12):28943-78. PubMed ID: 26690121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of lncRNAs in prostate cancer development and progression.
    Weiss M; Plass C; Gerhauser C
    Biol Chem; 2014 Nov; 395(11):1275-90. PubMed ID: 25153594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The long non-coding RNA PCGEM1 is regulated by androgen receptor activity in vivo.
    Parolia A; Crea F; Xue H; Wang Y; Mo F; Ramnarine VR; Liu HH; Lin D; Saidy NR; Clermont PL; Cheng H; Collins C; Wang Y; Helgason CD
    Mol Cancer; 2015 Feb; 14():46. PubMed ID: 25744782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor-Derived Exosomal Long Noncoding RNAs as Promising Diagnostic Biomarkers for Prostate Cancer.
    Wang YH; Ji J; Wang BC; Chen H; Yang ZH; Wang K; Luo CL; Zhang WW; Wang FB; Zhang XL
    Cell Physiol Biochem; 2018; 46(2):532-545. PubMed ID: 29614511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel androgen-reduced prostate-specific lncRNA, PSLNR, inhibits prostate-cancer progression in part by regulating the p53-dependent pathway.
    Wang D; Wan X; Zhang Y; Kong Z; Lu Y; Sun X; Huang Y; Ji C; Li D; Luo J; Gu W; Wang C; Li Y; Xu Y
    Prostate; 2019 Sep; 79(12):1362-1377. PubMed ID: 31269242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AR-V7 expression in circulating tumor cells as a potential prognostic marker in metastatic hormone-sensitive prostate cancer.
    Josefsson A; Damber JE; Welén K
    Acta Oncol; 2019 Nov; 58(11):1660-1664. PubMed ID: 31286815
    [No Abstract]   [Full Text] [Related]  

  • 31. Long non-coding RNAs in genitourinary malignancies: a whole new world.
    Flippot R; Beinse G; Boilève A; Vibert J; Malouf GG
    Nat Rev Urol; 2019 Aug; 16(8):484-504. PubMed ID: 31110275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Signaling through estrogen receptors modulates long non-coding RNAs in prostate cancer.
    Nanni S; Bacci L; Aiello A; Re A; Salis C; Grassi C; Pontecorvi A; Gaetano C; Farsetti A
    Mol Cell Endocrinol; 2020 Jul; 511():110864. PubMed ID: 32413384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNA: A newly deciphered "code" in prostate cancer.
    Zhang A; Zhang J; Kaipainen A; Lucas JM; Yang H
    Cancer Lett; 2016 Jun; 375(2):323-330. PubMed ID: 26965999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications.
    Ramnarine VR; Alshalalfa M; Mo F; Nabavi N; Erho N; Takhar M; Shukin R; Brahmbhatt S; Gawronski A; Kobelev M; Nouri M; Lin D; Tsai H; Lotan TL; Karnes RJ; Rubin MA; Zoubeidi A; Gleave ME; Sahinalp C; Wyatt AW; Volik SV; Beltran H; Davicioni E; Wang Y; Collins CC
    Gigascience; 2018 Jun; 7(6):. PubMed ID: 29757368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The evolution of long noncoding RNA acceptance in prostate cancer initiation, progression, and its clinical utility in disease management.
    Ramnarine VR; Kobelev M; Gibb EA; Nouri M; Lin D; Wang Y; Buttyan R; Davicioni E; Zoubeidi A; Collins CC
    Eur Urol; 2019 Nov; 76(5):546-559. PubMed ID: 31445843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long noncoding RNAs: new players in prostate cancer.
    Cheng W; Zhang Z; Wang J
    Cancer Lett; 2013 Oct; 339(1):8-14. PubMed ID: 23856029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel AR translational regulator lncRNA LBCS inhibits castration resistance of prostate cancer.
    Gu P; Chen X; Xie R; Xie W; Huang L; Dong W; Han J; Liu X; Shen J; Huang J; Lin T
    Mol Cancer; 2019 Jun; 18(1):109. PubMed ID: 31221168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The IncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancer.
    Prensner JR; Sahu A; Iyer MK; Malik R; Chandler B; Asangani IA; Poliakov A; Vergara IA; Alshalalfa M; Jenkins RB; Davicioni E; Feng FY; Chinnaiyan AM
    Oncotarget; 2014 Mar; 5(6):1434-8. PubMed ID: 24727738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LINC00675 activates androgen receptor axis signaling pathway to promote castration-resistant prostate cancer progression.
    Yao M; Shi X; Li Y; Xiao Y; Butler W; Huang Y; Du L; Wu T; Bian X; Shi G; Ye D; Fu G; Wang J; Ren S
    Cell Death Dis; 2020 Aug; 11(8):638. PubMed ID: 32801300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long non-coding RNAs and their potential impact on diagnosis, prognosis, and therapy in prostate cancer: racial, ethnic, and geographical considerations.
    Morgan R; da Silveira WA; Kelly RC; Overton I; Allott EH; Hardiman G
    Expert Rev Mol Diagn; 2021 Dec; 21(12):1257-1271. PubMed ID: 34666586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.